Christopher Accetta, MD
Obstetrics & Gynecology · Summerville, SCNPI 1407820384
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.4% of the total across 283 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 32 manufacturers reported payments, led by AbbVie at 28.3% of the total. Reporting peaked in 2022 at $1,632 and has fallen 84.2% since, to $258 in 2024.
Across 283 payments — averaging $17.24 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- Sumitomo Pharma America, Inc.$477
- Hologic Sales And Service, LLC$392
- Channel Medsystems, Inc.$244
- Mayne Pharma Commercial LLC$244
- Therapeuticsmd, Inc.$241
- plus $2K from 26 others
What the payments were for
- Food & beverage$4,85299%
- Education$281%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 94 | $1,382 |
| Sumitomo Pharma America, Inc. | 23 | $477 |
| Hologic Sales And Service, LLC | 16 | $392 |
| Channel Medsystems, Inc. | 2 | $244 |
| Mayne Pharma Commercial LLC | 13 | $244 |
| Therapeuticsmd, Inc. | 16 | $241 |
| Exeltis, USA Inc. | 15 | $235 |
| Myovant Sciences Inc. | 15 | $220 |
| Mylan Pharmaceuticals Inc. | 6 | $145 |
| Pfizer | 9 | $145 |
| Organon | 10 | $143 |
| Evofem Biosciences, Inc. | 9 | $134 |
| Bayer | 7 | $113 |
| Avion Pharmaceuticals | 6 | $90 |
| Shield Therapeutics Inc | 5 | $74 |
| Scynexis, Inc. | 3 | $67 |
| Optumhealth Care Solutions, LLC | 5 | $63 |
| Merck | 5 | $63 |
| Duchesnay USA Incorporated | 4 | $55 |
| Agile Therapeutics, Inc. | 3 | $52 |
| Lupin Inc. | 3 | $39 |
| Coopersurgical, Inc. | 1 | $36 |
| Exact Sciences | 2 | $35 |
| Astellas Pharma US Inc | 2 | $35 |
| AMAG Pharmaceuticals, Inc. | 2 | $28 |
| Johnson & Johnson | 1 | $22 |
| AstraZeneca | 1 | $22 |
| Aspira Women's Health Inc | 1 | $20 |
| Sage Therapeutics, LLC | 1 | $19 |
| Axonics, Inc. | 1 | $15 |
| Pacira Pharmaceuticals Incorporated | 1 | $15 |
| Gynesonics, Inc. | 1 | $14 |
How this compares
$4,880 in reported general payments places this provider in the 85th percentile of 673 obstetrics & gynecology providers in South Carolina.
See all obstetrics & gynecology providers in South Carolina →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Estradiol (Twice Weekly)Estradiol | 27 | $2,317 |
| Estradiol | 40 | $1,882 |
| Paroxetine Hcl | 21 | $242 |
| Medroxyprogesterone Acetate | 30 | $148 |
Paid to pharmacies, not to this prescriber.
Other obstetrics & gynecology in Summerville
- Martha CohenSummerville$10K
- Brittany StofkoSummerville$8K
- Jennifer HeinemannSummerville$7K
- Ronnie GivensSummerville$6K
- Hunter SmithSummerville$6K
- Christine HunterSummerville$6K
- William ReevesSummerville$6K
- Beth CookSummerville$6K
- Christopher JenningsAnderson$1.3M
- William ColemanGreenville$242K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.